Project Grant R01AG089605
Award Date
8/15/24
Completion Date
4/30/29
Dollars Obligated
$2.5M
Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Baltimore, MD 21205, USA
Similar Awards
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $654,238 to The University of Texas Health Science Center at San Antonio to study the role of senescent cells in Alzheimer's disease and related dementias (ADRD). The primary goals are to: Identify molecular markers and changes in the microenvironment of senescent neurons compared to healthy neurons, with a focus on their contribution to neuronal death in brain aging and ADRD (R21 phase). Use...
The National Institute on Aging (NIA), under the Aging Research Federal Grant Program (CFDA 93.866), awarded a $2,273,637 Project Grant to The Johns Hopkins University to conduct a comprehensive study of plasma and brain lipidomics (lipid profiling) and their associations with Alzheimer's disease (AD), dementia, and cognitive decline. The study will leverage novel Lipidyzer technology to quantify over 1,500 lipid species in plasma samples from 3,868 participants in the Cardiovascular Health...
This Project Grant award from the National Institute on Aging (NIA), part of the Aging Research program (CFDA 93.866), provides $622,086.00 to The Johns Hopkins University to conduct research on the role of the NOD2/RIPK2 signaling pathway in neuroinflammation and neurodegeneration in Alzheimer's disease. The 5-year project aims to elucidate the mechanisms of microglial activation by amyloid-beta oligomers, assess the involvement of the NOD2/RIPK2 pathway, determine the impact of selectively...
This $7,704,350 Project Grant awarded by the National Institute on Aging (CFDA 93.866 - Aging Research) aims to discover and develop new therapeutic strategies to delay or prevent dementia in Lewy body disorders (LBD). The grant supports a multi-project center at the University of Pennsylvania that investigates mechanisms underlying the heterogeneity of cognitive outcomes in synucleinopathies, which include conditions like Parkinson's disease, dementia with Lewy bodies, and Alzheimer's disease...
This $2,069,215 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) supports research by Case Western Reserve University to investigate the role of the beta-arrestin2-LMBRD2 pathway in the transmission and toxicity of pathological alpha-synuclein, which is a defining hallmark of Lewy body diseases such as Parkinson's disease and dementia with Lewy bodies. The research will utilize cellular and animal models to study the mechanisms by which beta-arrestin2...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $866,723 to The Johns Hopkins University for a project titled "Multi-Scale MRI-Based Diffeomorphometry of Pathology and Molecular Signatures Associated with Entorhinal Cortex Atrophy in Alzheimer's Disease". The project aims to integrate high-field post-mortem imaging, histological, and spatial transcriptomic data to link the spatial and temporal progression of MRI markers to...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, is funding research on the role of microglia/macrophages in Lewy body disorders. The total award amount is $231,826.00, with a project period from September 17, 2024 to August 31, 2026. The key objectives of the research are to: 1) identify the neural cell type most likely...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $3,128,604.00 to The University of Texas MD Anderson Cancer Center to investigate the relationships between immunosenescence, brain aging biomarkers, and cognition across non-human primate species with differing lifespans. The project aims to elucidate the role of the immune system in longevity, neurodegeneration, and cognitive decline, which may inform the development of immuno-restorative...
The National Institute on Aging (NIA) awarded a $717,491 Project Grant under its Aging Research program (CFDA 93.866) to New York University (NYU) School of Medicine to develop single domain antibodies (sdAbs) that can detect and clear alpha-synuclein (αSyn) in animal models of synucleinopathies. The project aims to evaluate the in vivo imaging potential, clearance mechanisms, and therapeutic efficacy of these sdAbs targeting αSyn, a key protein involved in neurodegenerative diseases like Lewy...
This Project Grant award of $766,133 from the National Institute on Aging (CFDA 93.866 - Aging Research) supports research to understand the mechanisms leading to amyloid-related imaging abnormalities (ARIA) that can occur with anti-amyloid immunotherapy for Alzheimer's disease. The research aims to: Determine the elimination pathway and clearance mechanism for chimeric anti-amyloid antibodies (ChAbs) in Alzheimer's disease mouse models. Examine how ARIA events develop in Alzheimer's disease...